医药品·生物科技产业的销售契约 (2020～2025年)

本报告提供了 2020 年至 2025 年製药和生物技术产业分销协议的详细资讯。它提供了双方已宣布的分销协议中的付款条款，并提供了有关付款条款和其他交易条款的宝贵见解。

主要优势

本报告提供读者以下主要优势：

• 了解 2020 年及以后的合约趋势
• 查看经销协议
• 基准分析：了解交易的市场价值
• 财务条款
• 合约目录：依公司（A-Z）、治疗领域、技术类型
• 按价值划分的主要合约
• 识别最活跃的承包商
• 识别每笔交易的资产和条款
• 存取合约文件：深入了解合约结构
• 尽职调查：评估与合作伙伴协调合约条款
• 节省数百小时的研究时间

调查范围

• 生物製药分销合约趋势
• 分销合约结构概述
• 製药和生物技术领域分销合约记录目录
• 按价值划分的主要分销合约
• 最活跃的经销承包商
• 主要经销合作伙伴资源

可利用契约的清单:

• 企业 (A～Z)
• 契约总额
• 治疗领域
• 技术类型

目录

摘要整理

第1章 简介

第2章 销售契约趋势

• 销售契约定义
• 2020年以后的销售契约趋势
  • 2020～2025年的销售契约:各年度
  • 2020～2025年的销售契约:各开发阶段
  • 2020～2025年的销售契约:各业界
  • 2020～2025年的销售契约:各治疗领域
  • 2020～2025年的销售契约:各技术类型
  • 2020～2025年的销售契约:最活跃的各企业
  • 纯分销协议的属性
  • 混合安排中分销协议的属性
• 为了调整合作伙伴，使之有作用销售契约的配合措施

第3章 销售契约结构:概要

• 销售契约结构
• 更广泛的销售契约的一环的销售权

第4章 主要销售契约

• 首位销售契约:各金额

第5章 最活跃的销售契约企业:前25家

• 最活跃的销售契约企业:前25家

第6章 含契约名录的销售契约

• 包含从2020年到2025年契约的销售契约
• 契约名录
• 契约名录- 各企业销售契约 (A-Z)
• 契约名录- 各治疗领域的销售契约
• 契约名录- 各技术类型的销售契约
• 关于Biopharma Research
• 目前联盟
• 目前契约
• Current Partnering的最近报告标题

Distribution Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter distribution deals.

Fully revised and updated, the report provides details of distribution deals from 2020 to 2025.

The report provides access to distribution deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of distribution deals announced since 2020 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual distribution contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of distribution dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in distribution as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of distribution deals.

Chapter 4 provides a review of the leading distribution deals since 2020. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active distribution dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of distribution deals organized by company A-Z, therapy, technology and industry type signed and announced since 2020 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the distribution deal.

The deal directory includes a comprehensive listing of all distribution deals announced since 2020. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in distribution dealmaking since 2020.

In conclusion, this report provides everything a prospective dealmaker needs to know about distribution alliances.

Key benefits

Distribution Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2020
• Browse distribution deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Distribution Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the distribution trends and structure of deals entered into by leading biopharma companies worldwide.

Distribution Deals in Pharmaceuticals and Biotechnology includes:

• Trends in distribution dealmaking in the biopharma industry
• Overview of distribution deal structure
• Directory of distribution deal records covering pharmaceutical and biotechnology
• The leading distribution deals by value
• Most active distribution dealmakers
• The leading distribution partnering resources

In Distribution Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Distribution Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for distribution deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

• 2.1. Introduction
• 2.2. Definition of distribution deals
• 2.3. Trends in distribution deals since 2020
  • 2.3.1. Distribution dealmaking by year, 2020-2025
  • 2.3.2. Distribution dealmaking by phase of development, 2020-2025
  • 2.3.3. Distribution dealmaking by industry sector, 2020-2025
  • 2.3.4. Distribution dealmaking by therapy area, 2020-2025
  • 2.3.5. Distribution dealmaking by technology type, 2020-2025
  • 2.3.6. Distribution dealmaking by most active company, 2020-2025
  • 2.3.7. Attributes of pure distribution deals
  • 2.3.8. Attributes of distribution in multi-component deals
• 2.4. Aligning partners to make the distribution agreement work

Chapter 3 - Overview of distribution deal structure

• 3.1. Introduction
• 3.2. Distribution agreement structure
• 3.3. Distribution rights as part of a wider alliance agreement

Chapter 4 - Leading distribution deals

• 4.1. Introduction
• 4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active distribution dealmakers

Chapter 6 - Distribution deals including contracts directory

• 6.1. Introduction
• 6.2. Distribution deals with contracts 2020-2025
• Deal directory
• Deal directory - distribution dealmaking by companies A-Z
• Deal directory - distribution dealmaking by therapy area
• Deal directory - distribution dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of distribution
• Figure 2: Trends in distribution deal announcements, 2020-2025
• Figure 3: Distribution deals signed at each phase of development, 2020-2025
• Figure 4: Distribution deals by industry sector, 2020-2025
• Figure 5: Distribution deals by therapy area, 2020-2025
• Figure 6: Distribution deals by technology type, 2020-2025
• Figure 7: Top 25 most active distribution dealmakers, 2020-2025
• Figure 8: Issues in implementing distribution agreements
• Figure 9: Distribution agreements - what should a contract include?
• Figure 10: Components of the distribution deal structure
• Figure 11: Top distribution deals by value 2020-2025
• Figure 12: Most active distribution dealmakers 2020-2025